The present invention relates to novel polypeptide constructs based on
peptides derived from Insulin-like Growth Factor I (IGF-1). The invention
also relates to novel uses for IGF-1-derived peptides, particularly for
the prevention and treatment of diseases involving regulation of cellular
growth or differentiation, regeneration and tissue repair.